menu
Latest:
- Product Recall – Risk of electrical shorts on Pacemakers
- Third Covid antibody treatment authorised by FDA
- Parkinson – Ketamine Trials to treat Parkinson disease approved by FDA
- COVID-19 – Vaccine benefits outweigh risks despite possible adverse events
- COVID-19 Study: Progesterone therapy could promote recovery in men
- Biotech CSL – 45% profit jump on half-year results
- Covid – Japan to indemnify families if relative dies due to vaccine
- Marijuana industry acquisition: Hexo – Zenabis Global
- FDA officially authorises the Johnson & Johnson coronavirus vaccine for Emergency use
- AstraZeneca second dose could improve immunity if delayed by up to 12 weeks